Clinical Trial Update: Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating lot consistency of a Clostridium difficile vaccine in healthy adults 65-85 years old; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Clostridium Difficile-associated Disease

Drugs mentioned

• Pfizer vaccine (Clostridium difficile)

Snippet

Sponsor: Pfizer | Conditions: Clostridium Difficile Associated Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-01-19